{"id":{"repo_id":"athens","oai_identifier":"oai:lib.uoa.gr:uoadl:1313466"},"canonical_url":"https://search.ndltd.org/etd/athens/oai:lib.uoa.gr:uoadl:1313466","repository":{"repo_id":"athens","name":"National and Kapodistrian University of Athens","base_url":"https://pergamos.lib.uoa.gr/uoa/dl/frontend/oaipmh"},"display":{"title":"Πλασμαφαίρεση στη TTP και HUS","abstract":"Στην παρούσα διπλωματική εργασία αναφερόμαστε για τη θεραπευτική πλασμαφαίρεση στη θρομβωτική θρομβοπενική πορφύρα και στο ουραιμικό σύνδρομο. Αναλύουμε την τεχνική της πλασμαφαίρεσης και επίσης την TTP –HUS. Στο τέλος γίνεται αναφορά από την εμπειρία της κλινικής στο πανεπιστημιακό γενικό νοσοκομείο ΑΤΤΙΚΟΝ από την έναρξη της λειτουργίας της έως και το έτος 2014.","abstract_html":"Στην παρούσα διπλωματική εργασία αναφερόμαστε για τη θεραπευτική πλασμαφαίρεση στη θρομβωτική θρομβοπενική πορφύρα και στο ουραιμικό σύνδρομο. Αναλύουμε την τεχνική της πλασμαφαίρεσης και επίσης την TTP –HUS. Στο τέλος γίνεται αναφορά από την εμπειρία της κλινικής στο πανεπιστημιακό γενικό νοσοκομείο ΑΤΤΙΚΟΝ από την έναρξη της λειτουργίας της έως και το έτος 2014.","abstract_has_math":false,"creators":["Δαρλαγιάννης Νικόλαος"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014","date_published":"2014","updated_at":"2026-11-19T05:23:06Z","subjects":[],"languages":["Ελληνικά","Greek"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["uoadl:1313466"],"render_values":[{"text":"uoadl:1313466","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://pergamos.lib.uoa.gr/uoa/dl/object/1313466","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://pergamos.lib.uoa.gr/uoa/dl/object/1313466","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://pergamos.lib.uoa.gr/uoa/dl/frontend/oaipmh?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Alib.uoa.gr%3Auoadl%3A1313466","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Δαρλαγιάννης Νικόλαος"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2014"]},{"key":"dc:type","label":"Dc Type","values":["born_digital_postgraduate_thesis","Διπλωματική Εργασία","Postgraduate Thesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["Ελληνικά","Greek"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["uoadl:1313466","https://pergamos.lib.uoa.gr/uoa/dl/object/1313466"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Στην παρούσα διπλωματική εργασία αναφερόμαστε για τη θεραπευτική πλασμαφαίρεση στη θρομβωτική θρομβοπενική πορφύρα και στο ουραιμικό σύνδρομο. Αναλύουμε την τεχνική της πλασμαφαίρεσης και επίσης την TTP –HUS. Στο τέλος γίνεται αναφορά από την εμπειρία της κλινικής στο πανεπιστημιακό γενικό νοσοκομείο ΑΤΤΙΚΟΝ από την έναρξη της λειτουργίας της έως και το έτος 2014.","In the following essay we will refer to the therapeutic plasmapheresis, in disease of Thrombotic Thrombocytopenic Purpura (T.T.P.) and in disease of Hemolytic Uremic Syndrome (H.U.S.) Plasmapheresis is the removal of components of plasma from the blood sush as antidotes or pathological elements. During plasmapheresis ,blood is initially withdrawn by syringe or catheter and then the plasma is obtained from the blood by special filters. After the separation , erythrocytes return to the person who follows yhe treatment ,and plasma is replaced by other liquids. Generally , plasmapheresis is considered a successful treatment method mainly for immune disorders with attributable mortality due to complications 3/10000 confer uses. The Thrombotic Thrombocytopenic Purpura or syndrome Moschkowits is characterized by scattered thrombosis of the microcirculation system and a syndrome of schistocytes in the peripheral blood , thrombocytopenia, neurologic symptoms, fever and renal involvement. It is believed that Hemolytic Uremic Syndrome and other cases of microangiopathic hemolytic anemia are different expressions of the same disease that it may be found more often in women and people 30-40 years old. Hemolytic Uremic Syndrome (H.U.S.) is also and a throbotic microangiopathic disease characterized by thrombocytopenia, hemolytic anemia, and varying degrees of renal impairment. In infants and young children is the most common cause of kidney failure. The clinical severity varies in proportion with the degree of renal involvement from mild to cortical necrosis accompanied by renal impairment. And the end we will refer to the experience of Hematological Unit of P.G.H. Attikon from its inception up to the year 2012."]},{"key":"dc:title","label":"Title","values":["Πλασμαφαίρεση στη TTP και HUS"]}]}],"canonical_facts":{"dc:creator":["Δαρλαγιάννης Νικόλαος"],"dc:date":["2014"],"dc:description":["Στην παρούσα διπλωματική εργασία αναφερόμαστε για τη θεραπευτική πλασμαφαίρεση στη θρομβωτική θρομβοπενική πορφύρα και στο ουραιμικό σύνδρομο. Αναλύουμε την τεχνική της πλασμαφαίρεσης και επίσης την TTP –HUS. Στο τέλος γίνεται αναφορά από την εμπειρία της κλινικής στο πανεπιστημιακό γενικό νοσοκομείο ΑΤΤΙΚΟΝ από την έναρξη της λειτουργίας της έως και το έτος 2014.","In the following essay we will refer to the therapeutic plasmapheresis, in disease of Thrombotic Thrombocytopenic Purpura (T.T.P.) and in disease of Hemolytic Uremic Syndrome (H.U.S.) Plasmapheresis is the removal of components of plasma from the blood sush as antidotes or pathological elements. During plasmapheresis ,blood is initially withdrawn by syringe or catheter and then the plasma is obtained from the blood by special filters. After the separation , erythrocytes return to the person who follows yhe treatment ,and plasma is replaced by other liquids. Generally , plasmapheresis is considered a successful treatment method mainly for immune disorders with attributable mortality due to complications 3/10000 confer uses. The Thrombotic Thrombocytopenic Purpura or syndrome Moschkowits is characterized by scattered thrombosis of the microcirculation system and a syndrome of schistocytes in the peripheral blood , thrombocytopenia, neurologic symptoms, fever and renal involvement. It is believed that Hemolytic Uremic Syndrome and other cases of microangiopathic hemolytic anemia are different expressions of the same disease that it may be found more often in women and people 30-40 years old. Hemolytic Uremic Syndrome (H.U.S.) is also and a throbotic microangiopathic disease characterized by thrombocytopenia, hemolytic anemia, and varying degrees of renal impairment. In infants and young children is the most common cause of kidney failure. The clinical severity varies in proportion with the degree of renal involvement from mild to cortical necrosis accompanied by renal impairment. And the end we will refer to the experience of Hematological Unit of P.G.H. Attikon from its inception up to the year 2012."],"dc:identifier":["uoadl:1313466","https://pergamos.lib.uoa.gr/uoa/dl/object/1313466"],"dc:language":["Ελληνικά","Greek"],"dc:title":["Πλασμαφαίρεση στη TTP και HUS"],"dc:type":["born_digital_postgraduate_thesis","Διπλωματική Εργασία","Postgraduate Thesis"]},"updated_at":"2026-11-19T05:23:06Z"}